Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion

Lydia Aguilar-Bryan; Colin G. Nichols; Sérgio W. Wechsler; John P. Clement IV; A. E. Boyd; Gabriela González; Haydée Herrera-Sosa; Kimberly Nguy; Joseph Bryan; Daniel A. Nelson

doi:10.1126/science.7716547

Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion

Lydia Aguilar-Bryan, Colin G. Nichols, Sérgio W. Wechsler, John P. Clement IV, A. E. Boyd, Gabriela González, Haydée Herrera-Sosa, Kimberly Nguy, Joseph Bryan, Daniel A. Nelson

Research output: Contribution to journal › Article › peer-review

1283 Scopus citations

Abstract

Sulfonylureas are a class of drugs widely used to promote insulin secretion in the treatment of non-insulin-dependent diabetes mellitus. These drugs interact with the sulfonylurea receptor of pancreatic β cells and inhibit the conductance of adenosine triphosphate (ATP)-dependent potassium (K _ATP) channels. Cloning of complementary DNAs for the high-affinity sulfonylurea receptor indicates that it is a member of the ATP-binding cassette or traffic ATPase superfamily with multiple membrane-spanning domains and two nucleotide binding folds. The results suggest that the sulfonylurea receptor may sense changes in ATP and ADP concentration, affect K_ATP channel activity, and thereby modulate insulin release.

Original language	English
Pages (from-to)	423-426
Number of pages	4
Journal	Science
Volume	268
Issue number	5209
DOIs	https://doi.org/10.1126/science.7716547
State	Published - 1995

Access to Document

10.1126/science.7716547

Cite this

@article{9adaee9b50874e7f868ea2cf3167a502,

title = "Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion",

abstract = "Sulfonylureas are a class of drugs widely used to promote insulin secretion in the treatment of non-insulin-dependent diabetes mellitus. These drugs interact with the sulfonylurea receptor of pancreatic β cells and inhibit the conductance of adenosine triphosphate (ATP)-dependent potassium (K ATP) channels. Cloning of complementary DNAs for the high-affinity sulfonylurea receptor indicates that it is a member of the ATP-binding cassette or traffic ATPase superfamily with multiple membrane-spanning domains and two nucleotide binding folds. The results suggest that the sulfonylurea receptor may sense changes in ATP and ADP concentration, affect KATP channel activity, and thereby modulate insulin release.",

author = "Lydia Aguilar-Bryan and Nichols, {Colin G.} and Wechsler, {S{\'e}rgio W.} and {Clement IV}, {John P.} and Boyd, {A. E.} and Gabriela Gonz{\'a}lez and Hayd{\'e}e Herrera-Sosa and Kimberly Nguy and Joseph Bryan and Nelson, {Daniel A.}",

year = "1995",

doi = "10.1126/science.7716547",

language = "English",

volume = "268",

pages = "423--426",

journal = "Science",

issn = "0036-8075",

number = "5209",

}

TY - JOUR

T1 - Cloning of the β cell high-affinity sulfonylurea receptor

T2 - A regulator of insulin secretion

AU - Aguilar-Bryan, Lydia

AU - Nichols, Colin G.

AU - Wechsler, Sérgio W.

AU - Clement IV, John P.

AU - Boyd, A. E.

AU - González, Gabriela

AU - Herrera-Sosa, Haydée

AU - Nguy, Kimberly

AU - Bryan, Joseph

AU - Nelson, Daniel A.

PY - 1995

Y1 - 1995

N2 - Sulfonylureas are a class of drugs widely used to promote insulin secretion in the treatment of non-insulin-dependent diabetes mellitus. These drugs interact with the sulfonylurea receptor of pancreatic β cells and inhibit the conductance of adenosine triphosphate (ATP)-dependent potassium (K ATP) channels. Cloning of complementary DNAs for the high-affinity sulfonylurea receptor indicates that it is a member of the ATP-binding cassette or traffic ATPase superfamily with multiple membrane-spanning domains and two nucleotide binding folds. The results suggest that the sulfonylurea receptor may sense changes in ATP and ADP concentration, affect KATP channel activity, and thereby modulate insulin release.

AB - Sulfonylureas are a class of drugs widely used to promote insulin secretion in the treatment of non-insulin-dependent diabetes mellitus. These drugs interact with the sulfonylurea receptor of pancreatic β cells and inhibit the conductance of adenosine triphosphate (ATP)-dependent potassium (K ATP) channels. Cloning of complementary DNAs for the high-affinity sulfonylurea receptor indicates that it is a member of the ATP-binding cassette or traffic ATPase superfamily with multiple membrane-spanning domains and two nucleotide binding folds. The results suggest that the sulfonylurea receptor may sense changes in ATP and ADP concentration, affect KATP channel activity, and thereby modulate insulin release.

UR - http://www.scopus.com/inward/record.url?scp=0029024314&partnerID=8YFLogxK

U2 - 10.1126/science.7716547

DO - 10.1126/science.7716547

M3 - Article

C2 - 7716547

AN - SCOPUS:0029024314

SN - 0036-8075

VL - 268

SP - 423

EP - 426

JO - Science

JF - Science

IS - 5209

ER -

Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion

Abstract

Access to Document

Other files and links

Fingerprint

Cite this